Toxin content and cytotoxicity of algal dietary supplements

dc.contributor.authorHeussner, Alexandra H.
dc.contributor.authorMazija, Lorena
dc.contributor.authorFastner, Juttadeu
dc.contributor.authorDietrich, Daniel R.
dc.date.accessioned2013-02-26T09:53:05Zdeu
dc.date.available2013-02-26T09:53:05Zdeu
dc.date.issued2012-12-01
dc.description.abstractBlue-green algae (Spirulina sp., Aphanizomenon flos-aquae) and Chlorella sp. are commercially distributed as organic algae dietary supplements. Cyanobacterial dietary products in particular have raised serious concerns, as they appeared to be contaminated with toxins e.g. microcystins (MCs) and consumers repeatedly reported adverse health effects following consumption of these products. The aim of this study was to determine the toxin contamination and the in vitro cytotoxicity of algae dietary supplement products marketed in Germany. In thirteen products consisting of Aph. flos-aquae, Spirulina and Chlorella or mixtures thereof, MCs, nodularins, saxitoxins, anatoxin-a and cylindrospermopsin were analyzed. Five products tested in an earlier market study were re-analyzed for comparison. Product samples were extracted and analyzed for cytotoxicity in A549 cells as well as for toxin levels by (1) phosphatase inhibition assay (PPIA), (2) Adda-ELISA and (3) LC-MS/MS. In addition, all samples were analyzed by PCR for the presence of the mcyE gene, a part of the microcystin and nodularin synthetase gene cluster. Only Aph. flos-aquae products were tested positive for MCs as well as the presence of mcyE. The contamination levels of the MC-positive samples were ≤ 1 μg MC-LR equivalents g(-1) dw. None of the other toxins were found in any of the products. However, extracts from all products were cytotoxic. In light of the findings, the distribution and commercial sale of Aph. flos-aquae products, whether pure or mixed formulations, for human consumption appear highly questionable.
dc.description.versionpublished
dc.identifier.citationToxicology and Applied Pharmacology ; 265 (2012), 2. - S. 263-271deu
dc.identifier.doi10.1016/j.taap.2012.10.005deu
dc.identifier.pmid23064102
dc.identifier.ppn379377365deu
dc.identifier.urihttp://kops.uni-konstanz.de/handle/123456789/22123
dc.language.isoengdeu
dc.legacy.dateIssued2013-02-26deu
dc.rightsterms-of-usedeu
dc.rights.urihttps://rightsstatements.org/page/InC/1.0/deu
dc.subject.ddc570deu
dc.titleToxin content and cytotoxicity of algal dietary supplementseng
dc.typeJOURNAL_ARTICLEdeu
dspace.entity.typePublication
kops.citation.bibtex
@article{Heussner2012-12-01Toxin-22123,
  year={2012},
  doi={10.1016/j.taap.2012.10.005},
  title={Toxin content and cytotoxicity of algal dietary supplements},
  number={2},
  volume={265},
  issn={0041-008X},
  journal={Toxicology and Applied Pharmacology},
  pages={263--271},
  author={Heussner, Alexandra H. and Mazija, Lorena and Fastner, Jutta and Dietrich, Daniel R.}
}
kops.citation.iso690HEUSSNER, Alexandra H., Lorena MAZIJA, Jutta FASTNER, Daniel R. DIETRICH, 2012. Toxin content and cytotoxicity of algal dietary supplements. In: Toxicology and Applied Pharmacology. 2012, 265(2), pp. 263-271. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2012.10.005deu
kops.citation.iso690HEUSSNER, Alexandra H., Lorena MAZIJA, Jutta FASTNER, Daniel R. DIETRICH, 2012. Toxin content and cytotoxicity of algal dietary supplements. In: Toxicology and Applied Pharmacology. 2012, 265(2), pp. 263-271. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2012.10.005eng
kops.citation.rdf
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/22123">
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-02-26T09:53:05Z</dcterms:available>
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dc:rights>terms-of-use</dc:rights>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/>
    <dcterms:title>Toxin content and cytotoxicity of algal dietary supplements</dcterms:title>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/22123"/>
    <dc:language>eng</dc:language>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Fastner, Jutta</dc:contributor>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:abstract>Blue-green algae (Spirulina sp., Aphanizomenon flos-aquae) and Chlorella sp. are commercially distributed as organic algae dietary supplements. Cyanobacterial dietary products in particular have raised serious concerns, as they appeared to be contaminated with toxins e.g. microcystins (MCs) and consumers repeatedly reported adverse health effects following consumption of these products. The aim of this study was to determine the toxin contamination and the in vitro cytotoxicity of algae dietary supplement products marketed in Germany. In thirteen products consisting of Aph. flos-aquae, Spirulina and Chlorella or mixtures thereof, MCs, nodularins, saxitoxins, anatoxin-a and cylindrospermopsin were analyzed. Five products tested in an earlier market study were re-analyzed for comparison. Product samples were extracted and analyzed for cytotoxicity in A549 cells as well as for toxin levels by (1) phosphatase inhibition assay (PPIA), (2) Adda-ELISA and (3) LC-MS/MS. In addition, all samples were analyzed by PCR for the presence of the mcyE gene, a part of the microcystin and nodularin synthetase gene cluster. Only Aph. flos-aquae products were tested positive for MCs as well as the presence of mcyE. The contamination levels of the MC-positive samples were ≤ 1 μg MC-LR equivalents g(-1) dw. None of the other toxins were found in any of the products. However, extracts from all products were cytotoxic. In light of the findings, the distribution and commercial sale of Aph. flos-aquae products, whether pure or mixed formulations, for human consumption appear highly questionable.</dcterms:abstract>
    <dc:contributor>Heussner, Alexandra H.</dc:contributor>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2013-02-26T09:53:05Z</dc:date>
    <dc:creator>Dietrich, Daniel R.</dc:creator>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dc:creator>Mazija, Lorena</dc:creator>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/22123/1/heussner_221238.pdf"/>
    <dcterms:issued>2012-12-01</dcterms:issued>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/22123/1/heussner_221238.pdf"/>
    <dcterms:bibliographicCitation>Toxicology and Applied Pharmacology ; 265 (2012), 2. - S. 263-271</dcterms:bibliographicCitation>
    <dc:creator>Heussner, Alexandra H.</dc:creator>
    <dc:contributor>Dietrich, Daniel R.</dc:contributor>
    <dc:contributor>Mazija, Lorena</dc:contributor>
    <dc:creator>Fastner, Jutta</dc:creator>
  </rdf:Description>
</rdf:RDF>
kops.description.openAccessopenaccessgreen
kops.flag.knbibliographytrue
kops.identifier.nbnurn:nbn:de:bsz:352-221238deu
kops.sourcefieldToxicology and Applied Pharmacology. 2012, <b>265</b>(2), pp. 263-271. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2012.10.005deu
kops.sourcefield.plainToxicology and Applied Pharmacology. 2012, 265(2), pp. 263-271. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2012.10.005deu
kops.sourcefield.plainToxicology and Applied Pharmacology. 2012, 265(2), pp. 263-271. ISSN 0041-008X. eISSN 1096-0333. Available under: doi: 10.1016/j.taap.2012.10.005eng
kops.submitter.emaillaura.liebermann@uni-konstanz.dedeu
relation.isAuthorOfPublication24e6677b-047c-47ed-9a3e-6a6aedfadaed
relation.isAuthorOfPublication9f045d6b-789b-4366-a87d-3a59d3641265
relation.isAuthorOfPublication1bbf5832-2b75-4182-ad74-4fcde1d6c6ca
relation.isAuthorOfPublication.latestForDiscovery24e6677b-047c-47ed-9a3e-6a6aedfadaed
source.bibliographicInfo.fromPage263
source.bibliographicInfo.issue2
source.bibliographicInfo.toPage271
source.bibliographicInfo.volume265
source.identifier.eissn1096-0333
source.identifier.issn0041-008X
source.periodicalTitleToxicology and Applied Pharmacology

Dateien

Originalbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
heussner_221238.pdf
Größe:
997.84 KB
Format:
Adobe Portable Document Format
heussner_221238.pdf
heussner_221238.pdfGröße: 997.84 KBDownloads: 2328

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Vorschaubild nicht verfügbar
Name:
license.txt
Größe:
1.92 KB
Format:
Plain Text
Beschreibung:
license.txt
license.txtGröße: 1.92 KBDownloads: 0